A concerning recent study reveals a significant link between the co-occurrence of insomnia and obstructive sleep apnea (OSA), a condition termed COMISA, and an elevated risk of cerebrovascular disease. Researchers found that individuals diagnosed with both conditions face a substantially higher likelihood of stroke and other related cardiovascular events compared to those with OSA alone. This research underscores the importance of recognizing and addressing both sleep disorders for comprehensive cardiovascular health.
The study, published in February 2026, analyzed data from a large cohort of over 330,000 patients using the TriNetX U.S. Collaborative Network, examining records from 2010 to 2023. The findings highlight COMISA as a distinct clinical phenotype associated with increased health risks, prompting a reevaluation of how these commonly co-occurring sleep disorders are managed. Understanding the combined impact of insomnia and sleep apnea is crucial, as both conditions are frequently underdiagnosed and undertreated.
COMISA and Cardiovascular Risk: A Closer Appear
Researchers categorized patients into two groups: those with COMISA (OSA plus an insomnia diagnosis within 90 days) and those with OSA only. After carefully matching the groups based on demographic, socioeconomic, comorbidity, and laboratory factors, they tracked the incidence of cardiovascular and cerebrovascular diseases (CCVDs) over a ten-year period. The results demonstrated that COMISA was associated with a 17% higher risk of cerebrovascular disease, including stroke [1].
Specifically, the study identified increased risks of arrhythmias, inflammatory and ischemic heart disease, and thrombotic disorders in the COMISA group. While atrial fibrillation/flutter and heart failure were slightly less frequent in those with COMISA, the overall association with time-to-first major adverse cardiovascular event was still notable. The hazard ratio for cerebrovascular disease was 1.17 (95% CI 1.14-1.20), indicating a statistically significant increase in risk.
Subgroup Analysis Reveals Consistent Patterns
The researchers further analyzed the data based on sex, continuous positive airway pressure (CPAP) use, and benzodiazepine/Z-drug use. Notably, the increased risks associated with COMISA remained consistent across these subgroups. This suggests that the detrimental effects of the combined sleep disorders are not limited by demographic factors or common treatment approaches. [1]
Obstructive sleep apnea, characterized by repeated interruptions in breathing during sleep, is already known to contribute to cardiovascular problems. [2] The addition of insomnia appears to exacerbate these risks, potentially due to the combined effects on inflammation, blood pressure, and sympathetic nervous system activity. The study did not delve into the specific mechanisms driving this increased risk, but it provides a strong impetus for further investigation.
Implications for Clinical Practice and Future Research
These findings have significant implications for clinical practice. Healthcare providers should be vigilant in screening for both insomnia and OSA in patients with cardiovascular risk factors, and consider a combined treatment approach when both conditions are present. Early diagnosis and intervention may help mitigate the increased risks associated with COMISA.
Further research is needed to explore the optimal treatment strategies for COMISA, including the potential benefits of cognitive behavioral therapy for insomnia (CBT-I), CPAP therapy for OSA, and the judicious use of pharmacotherapy. Understanding the underlying mechanisms driving the increased cardiovascular risk will also be crucial for developing targeted interventions. The study authors emphasize that COMISA should be recognized as a high-risk clinical phenotype requiring proactive management.
The increasing recognition of COMISA as a distinct sleep disorder with significant cardiocerebrovascular implications [3] highlights the complex interplay between sleep and overall health. Addressing sleep disorders is no longer solely a matter of improving quality of life; We see increasingly recognized as a critical component of cardiovascular disease prevention.
Disclaimer: This article provides informational content and should not be considered medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.
What are your thoughts on the growing awareness of combined sleep disorders? Share your experiences and insights in the comments below. Don’t forget to share this article with anyone who might benefit from this critical information.
